In February, Pfizer began its sixth season. science winsour flagship podcast that recently reached 3 million downloads.
The season finale focuses on the future of technology and artificial intelligence (AI) and what they mean for cancer research and treatment. Cancer research is advancing more rapidly than ever before, but that progress is not always reflected in the patient experience. AI may be starting to change that. final episode of science wins Season 6 will trace the human journey from the moment of diagnosis to the real-world barriers that determine access to treatment, focusing on how AI is impacting the cancer patients at the center of the story.
science wins puts listeners under the microscope on some of the most promising medical innovations, exploring treatments that have the potential to shape the future of medicine and bring new hope to patients around the world. Hosted by Dr. Raven Baxter (also known as Raven the Science Master), Season 6 focuses on oncology, from the rise of early-onset cancer and precision medicine to survivorship and the role of women in changing the way we understand, treat, and live with cancer.
In the final episode,Pace of Science: AI in Cancer TreatmentRaven will speak with Jeff Legos, Pfizer’s Chief Oncology Officer, and other industry experts about how Pfizer is integrating AI and digital technologies within the company, from how we detect cancer to how we design treatments, and discuss how these tools can accelerate progress in oncology, help patients regain control, and connect scientific advances with real-world cancer treatments.
The episode concludes the season with a wide-ranging look at how AI is being applied as the fight against cancer continues.
Listen to the season finale of Science Will Win wherever you get your podcasts.
